End-to-end automation for the in-house detection of targeted cancer mutations in KRAS, NRAS, BRAF and EGFR

Abstract Background The Idylla mutation test is a fully automated, real-time PCR-based assay for the targeted detection of cancer mutations in the key oncogenes KRAS , NRAS , BRAF and EGFR . The assay has a quick turnaround time and is cost effective lending itself for local implementation in a hospital setting. Methods The Idylla mutation test was validated on a total of 182 formalin-fixed paraffin-embedded (FFPE) cancer tissue samples, and a retrospective review of 115 patients who had the Idylla mutation test ordered at Tufts Medical Center (Boston, USA) was performed over 18 months. Results The validation yielded 100% sensitivity, 100% specificity, 100% overall accuracy, positive predictive value of 100%, and negative predictive value of 100%. The limit of detection (LOD) was ≤ 1%. The average turnaround time (TAT) from surgical specimen retrieval to result reporting was 14.7 days, from specimen receipt in the testing laboratory to reporting 2.8 days. The mutation detection rate was 27.4%. Conclusions The Idylla mutation test is highly accurate. To obtain the possible short turnaround time of the assay, efficient intradepartmental workflows are critical. The use of the assay in non-small cell lung cancer (NSCLC) is beneficial to resections in tumor stages 1–3. In cases where the Idylla groups multiple mutations into one reporting category, the actual underlying mutation cannot be identified. In instances where ambiguous results have clinical implications, as well as for normal Idylla results, follow-up with Next Generation Sequencing (NGS) is warranted.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11495083/v1
Primary Topic
Lung Cancer Treatments and Mutations
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

End-to-end automation for the in-house detection of targeted cancer mutations in KRAS, NRAS, BRAF and EGFR

Ulrike P. Kappes, Long H. Ngo, Monika Seth
Research Square
Lung Cancer Treatments and Mutations
preprint

End-to-end automation for the in-house detection of targeted cancer mutations in KRAS, NRAS, BRAF and EGFR

Ulrike P. Kappes, Long H. Ngo, Monika Seth
preprint en

Abstract

Abstract Background The Idylla mutation test is a fully automated, real-time PCR-based assay for the targeted detection of cancer mutations in the key oncogenes KRAS , NRAS , BRAF and EGFR . The assay has a quick turnaround time and is cost effective lending itself for local implementation in a hospital setting. Methods The Idylla mutation test was validated on a total of 182 formalin-fixed paraffin-embedded (FFPE) cancer tissue samples, and a retrospective review of 115 patients who had the Idylla mutation test ordered at Tufts Medical Center (Boston, USA) was performed over 18 months. Results The validation yielded 100% sensitivity, 100% specificity, 100% overall accuracy, positive predictive value of 100%, and negative predictive value of 100%. The limit of detection (LOD) was ≤ 1%. The average turnaround time (TAT) from surgical specimen retrieval to result reporting was 14.7 days, from specimen receipt in the testing laboratory to reporting 2.8 days. The mutation detection rate was 27.4%. Conclusions The Idylla mutation test is highly accurate. To obtain the possible short turnaround time of the assay, efficient intradepartmental workflows are critical. The use of the assay in non-small cell lung cancer (NSCLC) is beneficial to resections in tumor stages 1–3. In cases where the Idylla groups multiple mutations into one reporting category, the actual underlying mutation cannot be identified. In instances where ambiguous results have clinical implications, as well as for normal Idylla results, follow-up with Next Generation Sequencing (NGS) is warranted.

Research Square
Beth Israel Deaconess Medical Center (US)
Good health and well-being
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon